Back to Search Start Over

Duration of viral shedding and culture positivity with postvaccination SARS-CoV-2 delta variant infections

Authors :
Mark J. Siedner
Julie Boucau
Rebecca F. Gilbert
Rockib Uddin
Jonathan Luu
Sebastien Haneuse
Tammy Vyas
Zahra Reynolds
Surabhi Iyer
Grace C. Chamberlin
Robert H. Goldstein
Crystal M. North
Chana A. Sacks
James Regan
James P. Flynn
Manish C. Choudhary
Jatin M. Vyas
Amy K. Barczak
Jacob E. Lemieux
Jonathan Z. Li
Source :
JCI Insight, Vol 7, Iss 2 (2022)
Publication Year :
2022
Publisher :
American Society for Clinical investigation, 2022.

Abstract

Isolation guidelines for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are largely derived from data collected prior to the emergence of the delta variant. We followed a cohort of ambulatory patients with postvaccination breakthrough SARS-CoV-2 infections with longitudinal collection of nasal swabs for SARS-CoV-2 viral load quantification, whole-genome sequencing, and viral culture. All delta variant infections in our cohort were symptomatic, compared with 64% of non-delta variant infections. Symptomatic delta variant breakthrough infections were characterized by higher initial viral load, longer duration of virologic shedding by PCR, greater likelihood of replication-competent virus at early stages of infection, and longer duration of culturable virus compared with non-delta variants. The duration of time since vaccination was also correlated with both duration of PCR positivity and duration of detection of replication-competent virus. Nonetheless, no individuals with symptomatic delta variant infections had replication-competent virus by day 10 after symptom onset or 24 hours after resolution of symptoms. These data support US CDC isolation guidelines as of November 2021, which recommend isolation for 10 days or until symptom resolution and reinforce the importance of prompt testing and isolation among symptomatic individuals with delta breakthrough infections. Additional data are needed to evaluate these relationships among asymptomatic and more severe delta variant breakthrough infections.

Details

Language :
English
ISSN :
23793708
Volume :
7
Issue :
2
Database :
Directory of Open Access Journals
Journal :
JCI Insight
Publication Type :
Academic Journal
Accession number :
edsdoj.90bbd3e2fac74e5f9bf5980bad4e7da2
Document Type :
article
Full Text :
https://doi.org/10.1172/jci.insight.155483